This is an old video relating to the original extension something like a year ago when they only had a handful of subjects.
There is now a new extension recently posted showing the trial has been extended from 2 to 3 years.
I'm actually fairly confident in this trial showing some effectiveness - the preclinical data is strong. And the good news is that it is a potential add-on to mostly any other therapy.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.